Compare IRTC & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | CGAU |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.6B |
| IPO Year | 2016 | 2021 |
| Metric | IRTC | CGAU |
|---|---|---|
| Price | $126.20 | $23.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $197.92 | $16.67 |
| AVG Volume (30 Days) | 706.5K | ★ 1.5M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $747,138,000.00 | N/A |
| Revenue This Year | $19.60 | $25.17 |
| Revenue Next Year | $15.94 | $13.62 |
| P/E Ratio | ★ N/A | $11.74 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.85 | $7.68 |
| 52 Week High | $210.01 | $24.16 |
| Indicator | IRTC | CGAU |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 72.94 |
| Support Level | $104.17 | $14.84 |
| Resistance Level | $136.70 | N/A |
| Average True Range (ATR) | 6.64 | 0.75 |
| MACD | 0.20 | 0.24 |
| Stochastic Oscillator | 52.44 | 84.00 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.